Schedule 13G ownership disclosure
CAMP4 Therapeutics Corp.
Common Stock, par value $0.0001 per share · CUSIP: 13463J101
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- HarbourVest Partners L.P.
Shares: 1,271,948 · Class: 2.7%
- HarbourVest Partners, LLC
Shares: 1,271,948 · Class: 2.7%
- SMRS-TOPE LLC
Shares: 1,271,948 · Class: 2.7%
- HVST-TOPE LLC
Shares: 1,271,948 · Class: 2.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-226248
- Form type
- SCHEDULE 13G/A
- Filer
- Camp4 Therapeutics Corp
- CIK
- CIK 1736730
- Filed
- Oct 01, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership